132 related articles for article (PubMed ID: 24942027)
21. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study.
Wang LL; Filippi RZ; Zurakowski D; Archibald T; Vargas SO; Voss SD; Shamberger RC; Davies K; Kozakewich H; Perez-Atayde AR
Am J Surg Pathol; 2010 Mar; 34(3):287-99. PubMed ID: 20118773
[TBL] [Abstract][Full Text] [Related]
22. Sialoblastoma and hepatoblastoma in a newborn infant.
Stones DK; Jansen JC; Griessel D
Pediatr Blood Cancer; 2009 Jul; 52(7):883-5. PubMed ID: 19156857
[TBL] [Abstract][Full Text] [Related]
23. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma.
Venkatramani R; Stein JE; Sapra A; Genyk Y; Jhaveri V; Malogolowkin M; Mascarenhas L
Br J Surg; 2015 Jan; 102(1):108-13. PubMed ID: 25349947
[TBL] [Abstract][Full Text] [Related]
24. Hepatoblastoma: the Indiana experience with preoperative chemotherapy for inoperable tumors; clinicopathological considerations.
Heifetz SA; French M; Correa M; Grosfeld JL
Pediatr Pathol Lab Med; 1997; 17(6):857-74. PubMed ID: 9353826
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy for suspected hepatoblastoma without efforts at surgical resection is a bad practice.
Finegold MJ
Med Pediatr Oncol; 2002 Nov; 39(5):484-6. PubMed ID: 12228904
[TBL] [Abstract][Full Text] [Related]
26. Effects of P-glycoprotein modulation on the chemotherapy of xenotransplanted human hepatoblastoma.
Warmann SW; Heitmann H; Teichmann B; Gratz KF; Ruck P; Hunger M; Fuchs J
Pediatr Hematol Oncol; 2005; 22(5):373-86. PubMed ID: 16020127
[TBL] [Abstract][Full Text] [Related]
27. Teratoid hepatoblastoma.
Buccoliero AM; Castiglione F; Maio V; Moncini D; Sardi I; Taddei A; Martin A; Messineo A; Taddei GL
Fetal Pediatr Pathol; 2008; 27(6):274-81. PubMed ID: 19065325
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
Perilongo G; Maibach R; Shafford E; Brugieres L; Brock P; Morland B; de Camargo B; Zsiros J; Roebuck D; Zimmermann A; Aronson D; Childs M; Widing E; Laithier V; Plaschkes J; Pritchard J; Scopinaro M; MacKinlay G; Czauderna P
N Engl J Med; 2009 Oct; 361(17):1662-70. PubMed ID: 19846851
[TBL] [Abstract][Full Text] [Related]
29. [Primary and secondary inoperable teratoid hepatoblastoma--multidisciplinary management].
Lackner H; Urban C; Sauer H; Lammer J; Pakisch B; Kaulfersch W; Gamillscheg A; Slavc I; Riccabona M; Klos I
Padiatr Padol; 1990; 25(5):299-312. PubMed ID: 1705020
[TBL] [Abstract][Full Text] [Related]
30. Carboplatin and doxorubicin (CARDOX) for nonmetastatic hepatoblastoma: a discouraging pilot study.
Dall'Igna P; Cecchetto G; Dominici C; Donfrancesco A; Carli M; Indolfi P; Guglielmi M; Perilongo G
Med Pediatr Oncol; 2001 Feb; 36(2):332-4. PubMed ID: 11452948
[No Abstract] [Full Text] [Related]
31. Hepatoblastoma in association with bilateral polycystic kidneys.
Kummerfeld M; Klaunick G; Drückler E; Classen CF; Hauenstein C; Stuhldreier G
J Pediatr Surg; 2010 Nov; 45(11):e23-5. PubMed ID: 21034924
[TBL] [Abstract][Full Text] [Related]
32. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.
Carceller A; Blanchard H; Champagne J; St-Vil D; Bensoussan AL
J Pediatr Surg; 2001 May; 36(5):755-9. PubMed ID: 11329582
[TBL] [Abstract][Full Text] [Related]
33. Hepatoblastoma in a neonate: a hypervascular presentation mimicking hemangioendothelioma.
Ingram JD; Yerushalmi B; Connell J; Karrer FM; Tyson RW; Sokol RJ
Pediatr Radiol; 2000 Nov; 30(11):794-7. PubMed ID: 11100498
[TBL] [Abstract][Full Text] [Related]
34. Relationship of β-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma.
Gupta K; Rane S; Das A; Marwaha RK; Menon P; Rao KL
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e320-8. PubMed ID: 22735888
[TBL] [Abstract][Full Text] [Related]
35. DLK1, a serum marker for hepatoblastoma in young infants.
Falix FA; Aronson DC; Lamers WH; Hiralall JK; Seppen J
Pediatr Blood Cancer; 2012 Oct; 59(4):743-5. PubMed ID: 22180200
[TBL] [Abstract][Full Text] [Related]
36. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal hamartoma of the liver mimicking hepatoblastoma.
Unal E; Koksal Y; Akcoren Z; Tavl L; Gunel E; Kerimoglu U
J Pediatr Hematol Oncol; 2008 Jun; 30(6):458-60. PubMed ID: 18525464
[TBL] [Abstract][Full Text] [Related]
38. Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin.
Sivaprakasam P; Gupta AA; Greenberg ML; Capra M; Nathan PC
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e226-30. PubMed ID: 21792028
[TBL] [Abstract][Full Text] [Related]
39. [Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
Pan C; Tang JY; Chen J; Xue HL; Dong L; Zhou M; Jiang H; Ye QD; Gu LJ
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):659-62. PubMed ID: 19695195
[TBL] [Abstract][Full Text] [Related]
40. Combined treatment of hepatoblastoma with transcatheter arterial chemoembolization and surgery.
Xuewu J; Jianhong L; Xianliang H; Zhongxian C
Pediatr Hematol Oncol; 2006; 23(1):1-9. PubMed ID: 16326406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
